APGZX
Price
$104.70
Change
-$0.26 (-0.25%)
Updated
May 9 closing price
Net Assets
25.22B
GAFFX
Price
$72.65
Change
-$0.09 (-0.12%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

APGZX vs GAFFX

Header iconAPGZX vs GAFFX Comparison
Open Charts APGZX vs GAFFXBanner chart's image
AB Large Cap Growth Z
Price$104.70
Change-$0.26 (-0.25%)
VolumeN/A
Net Assets25.22B
American Funds Growth Fund of Amer F3
Price$72.65
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets285.48B
APGZX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
APGZX vs. GAFFX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGZX is a Buy and GAFFX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 285B vs. APGZX (25.2B). GAFFX pays higher dividends than APGZX: GAFFX (0.70) vs APGZX (0.09). APGZX was incepted earlier than GAFFX: APGZX (10 years) vs GAFFX (8 years). APGZX (0.51) is less costly to investors than GAFFX (0.30). APGZX is a more actively managed with annual turnover of: 30.00 vs. GAFFX (25.00). GAFFX has a lower initial minimum investment than APGZX: GAFFX (1000000) vs APGZX (2000000). GAFFX annual gain was more profitable for investors over the last year : 3.51 vs. APGZX (0.80). APGZX return over 5 years is better than : 61.37 vs. GAFFX (46.03).
APGZXGAFFXAPGZX / GAFFX
Total Expense Ratio0.510.30170%
Annual Report Gross Expense Ratio0.510.30170%
Fund Existence10 years8 years-
Gain YTD-4.200-2.444172%
Front LoadN/AN/A-
Min. Initial Investment20000001000000200%
Min. Initial Investment IRAN/AN/A-
Net Assets25.2B285B9%
Annual Yield % from dividends0.090.7013%
Returns for 1 year0.803.5123%
Returns for 3 years44.4334.08130%
Returns for 5 years61.3746.03133%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
PENN15.640.35
+2.29%
PENN Entertainment
CRL138.79-2.57
-1.82%
Charles River Laboratories International
ACRS1.26-0.05
-3.82%
Aclaris Therapeutics